Hilkka Soininen Selected Research

dimethylaminoethanol pyroglutamate

1/2012

Effect of six months of treatment with V0191 in patients with suspected prodromal Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hilkka Soininen Research Topics

Disease

185	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2000
74	Dementia (Dementias) 03/2022 - 01/2002
66	Cognitive Dysfunction 10/2022 - 09/2004
28	Atrophy 01/2021 - 02/2005
14	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021 - 11/2002
11	Disease Progression 01/2021 - 10/2009
10	Amyloid Plaque 01/2022 - 01/2002
9	Normal Pressure Hydrocephalus 01/2019 - 11/2012
8	Inflammation (Inflammations) 01/2021 - 10/2008
6	Parkinson Disease (Parkinson's Disease) 12/2017 - 01/2003
4	Genetic Risk Score 01/2021 - 01/2015
4	Insulin Resistance 01/2020 - 06/2012
4	Brain Diseases (Brain Disorder) 10/2019 - 01/2012
4	Frontotemporal Dementia (Semantic Dementia) 01/2019 - 07/2009
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 04/2017
3	Down Syndrome (Down's Syndrome) 10/2021 - 01/2014
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 06/2014
3	Tauopathies 11/2019 - 01/2011
3	Infarction (Infarctions) 01/2019 - 02/2008
3	Memory Disorders (Memory Loss) 11/2018 - 01/2013
3	Neuroblastoma 06/2013 - 12/2009
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2012 - 02/2008
3	Hypertension (High Blood Pressure) 01/2011 - 01/2002
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2019 - 02/2012
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2019 - 02/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 03/2016
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018 - 09/2014
2	Hypoxia (Hypoxemia) 01/2017 - 08/2015
2	Skin Neoplasms (Skin Cancer) 11/2015 - 11/2012
2	Obesity 01/2014 - 10/2005
2	Synucleinopathies 01/2012 - 01/2008
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2012 - 08/2011
1	Hypercholesterolemia 01/2021

Drug/Important Bio-Agent (IBA)

79	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2005
62	Amyloid (Amyloid Fibrils)IBA 10/2022 - 04/2005
47	Apolipoproteins E (ApoE)IBA 01/2022 - 08/2002
32	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2003
23	ApolipoproteinsIBA 01/2020 - 08/2002
14	Peptides (Polypeptides)IBA 01/2019 - 03/2000
11	CholesterolIBA 01/2022 - 01/2002
11	tau Proteins (tau Protein)IBA 01/2022 - 11/2002
11	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2015 - 12/2009
9	Pemetrexed (MTA)FDA Link 12/2020 - 02/2005
9	Amyloid beta-PeptidesIBA 01/2017 - 09/2007
8	LipidsIBA 09/2019 - 01/2002
5	Biological ProductsIBA 12/2020 - 10/2009
5	CalciumIBA 08/2015 - 02/2008
5	EnzymesIBA 01/2014 - 06/2008
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2008
4	Apolipoprotein E4IBA 01/2017 - 09/2004
4	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2015 - 02/2009
4	Blood Proteins (Serum Proteins)IBA 11/2014 - 07/2010
3	Fortasyn ConnectIBA 01/2021 - 12/2017
3	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 02/2011
3	Insulin (Novolin)FDA Link 01/2020 - 06/2012
3	Hormones (Hormone)IBA 04/2017 - 01/2014
3	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2017 - 01/2014
3	Presenilin-1IBA 06/2013 - 03/2011
3	ButyrylcholinesteraseIBA 08/2009 - 04/2008
3	Donepezil (Aricept)FDA LinkGeneric 12/2007 - 01/2003
2	Pharmaceutical PreparationsIBA 10/2021 - 05/2014
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 10/2008
2	C-Reactive ProteinIBA 01/2019 - 10/2018
2	Glycoproteins (Glycoprotein)IBA 01/2019 - 10/2008
2	Lipoproteins (Lipoprotein)IBA 01/2019 - 10/2016
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 01/2013
2	SynucleinsIBA 01/2019 - 01/2008
2	FatsIBA 11/2018 - 12/2008
2	IronIBA 01/2017 - 02/2008
2	Complement System Proteins (Complement)IBA 01/2016 - 08/2012
2	BMS 708163IBA 11/2015 - 11/2012
2	pleiotrophin (HARP)IBA 07/2015 - 02/2015
2	Opioid Receptors (Opioid Receptor)IBA 01/2015 - 06/2011
2	Cholinergic Agents (Cholinergics)IBA 01/2015 - 11/2011
2	ClusterinIBA 11/2014 - 07/2010
2	AntioxidantsIBA 01/2014 - 12/2013
2	TocotrienolsIBA 12/2013 - 10/2012
2	Vitamin E FDA LinkGeneric 12/2013 - 10/2012
2	Tocopherols (Tocopherol)IBA 12/2013 - 10/2012
2	GranulinsIBA 01/2013 - 07/2009
2	CytokinesIBA 01/2013 - 01/2011
2	UbiquitinIBA 01/2012 - 11/2005
2	Antihypertensive Agents (Antihypertensives)IBA 01/2011 - 01/2002
2	Dietary Fats (Dietary Fat)IBA 12/2008 - 07/2008
2	Insulysin (Insulin-Degrading Enzyme)IBA 06/2008 - 09/2007
1	antineoplaston A10 (A 10)IBA 01/2022
1	sharpinIBA 01/2021
1	27-hydroxycholesterolIBA 01/2021
1	OxysterolsIBA 01/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021
1	Glial Fibrillary Acidic ProteinIBA 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	KynurenineIBA 01/2021
1	C-PeptideIBA 01/2020

Therapy/Procedure

9	Therapeutics 04/2017 - 01/2009
5	Cognitive Training 03/2022 - 06/2015
4	Activities of Daily Living (ADL) 08/2013 - 01/2004
3	Transcranial Magnetic Stimulation 01/2011 - 07/2008
2	Cerebrospinal Fluid Shunts 12/2017 - 01/2013